{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:10:46Z","timestamp":1792789846155,"version":"4.5.0"},"reference-count":129,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.1080\/13543784.2024.2326028","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T04:14:09Z","timestamp":1709698449000},"page":"371-387","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":43,"title":["Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trials"],"prefix":"10.1080","volume":"33","author":[{"given":"David L.","family":"Paterson","sequence":"first","affiliation":[{"name":"ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore"},{"name":"Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02185-7"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12163"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00181-19"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41429-023-00629-8"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac078"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106776"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad061"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00389-17"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2022.05.011"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00069-5"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.1c00331"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv166"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv239"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02229-19"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00091"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00128-19"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01118-23"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02529-16"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa036"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab213"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01238-17"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00682-18"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01484-18"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00500-23"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-023-00606-x"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac280"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac110"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00440-23"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00879-22"},{"key":"e_1_3_5_33_1","unstructured":"[cited 2024 Jan 2]. Available from: www.shionogi.com\/us\/en\/news\/2023\/06"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01535"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2017.104"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01576-17"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01120-23"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad242"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2022.07.006"},{"key":"e_1_3_5_40_1","article-title":"Safety, tolerability, and pharmacokinetics of KSP-1007 after single and multiple ascending doses alone or in combination with meropenem in healthy subjects","author":"Dansky H.","year":"2023","unstructured":"Dansky H. Safety, tolerability, and pharmacokinetics of KSP-1007 after single and multiple ascending doses alone or in combination with meropenem in healthy subjects. ASM Microbe; Houston. 2023.","journal-title":"ASM Microbe"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.01.029"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02415-19"},{"key":"e_1_3_5_43_1","unstructured":"[cited 2024 Jan 2]. Available from: www.adjutecpharma.com\/news"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70580-1"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29234-3"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.9b00217"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00935-19"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa217"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00739-21"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00426-23"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00505-23"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00139-22"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.829592"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01517-20"},{"key":"e_1_3_5_55_1","unstructured":"[cited 2024 Jan 2]. Available from: www.micurxchina.com\/news"},{"key":"e_1_3_5_56_1","article-title":"BWC0977, a novel dual target topoisomerase inhibitor: antimicrobial potency, spectrum and mechanism of action","author":"Hameed S","year":"2019","unstructured":"Hameed S, Sharma S, Nandishaiah R. BWC0977, a novel dual target topoisomerase inhibitor: antimicrobial potency, spectrum and mechanism of action. ECCMID; Amsterdam. 2019.","journal-title":"ECCMID"},{"key":"e_1_3_5_57_1","article-title":"In vitro activity of BWC0977 (a novel bacterial topoisomerase inhibitor) and comparators against recent clinical and molecularly characterized enterobacteriaceae and non-fermenter isolates from the United states and Europe","author":"Huband M","year":"2019","unstructured":"Huband M, Lindley J, Watters A, et al. In vitro activity of BWC0977 (a novel bacterial topoisomerase inhibitor) and comparators against recent clinical and molecularly characterized enterobacteriaceae and non-fermenter isolates from the United states and Europe. ECCMID; Amsterdam. 2019.","journal-title":"ECCMID"},{"key":"e_1_3_5_58_1","unstructured":"[cited 2024 Feb 4]. Available from: www.bugworksresearch.com\/pipeline"},{"key":"e_1_3_5_59_1","unstructured":"[cited 2024 Feb 2]. Available from: www.recce.com.au\/company-announcements\/"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad226"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2023.02.005"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-023-04616-7"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106659"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00386-11"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat7520"},{"key":"e_1_3_5_66_1","unstructured":"[cited 2024 Jan 2]. Available from: www.aridispharma.com\/ar-501\/"},{"key":"e_1_3_5_67_1","volume-title":"9th International Symposium on the Diabetic Foot","author":"Millard J","year":"2023","unstructured":"Millard J Broad-spectrum, potent activity of pravibismane versus comparators against diabetic foot ulcer infection patient isolates collected in a phase ib study. 9th International Symposium on the Diabetic Foot; Amsterdam. 2023."},{"key":"e_1_3_5_68_1","unstructured":"[cited 2023 Dec 17]. Available from: www.microbioncorp.com\/pipeline"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114515"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.07.001"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa370"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0737-6"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02204-20"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06873-0"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad500.1749"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2294854"},{"key":"e_1_3_5_77_1","unstructured":"[cited 2024 Jan 1]. Available from: www.asieris.com\/pipeline"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01751-19"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02188-18"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-022-03317-y"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5560060601"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac105"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105462"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00437"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00552-21"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00934-22"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01304-21"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab425"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-023-04562-4"},{"key":"e_1_3_5_90_1","unstructured":"[cited 2024 Jan 1]. Available from: www.armatapharma.com\/pipeline"},{"key":"e_1_3_5_91_1","volume-title":"North American Cystic Fibrosis Conference 2023","author":"Rappo U","unstructured":"Rappo U, Kahan-Hanum M, Ussery X A phase 1b\/2a randomized, double-blind, placebo-controlled, multicenter study evaluating nebulized phage therapy in Cystic Fibrosis Subjects with chronic Pseudomonas aeruginosa pulmonary infection. North American Cystic Fibrosis Conference 2023; Toronto."},{"key":"e_1_3_5_92_1","unstructured":"[cited 2023 Nov 29]. Available from: www.biomx.com\/our-pipeline\/"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-07047-5"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01759-y"},{"key":"e_1_3_5_95_1","unstructured":"[cited 2023 Dec 23]. Available from: www.sniprbiome.com\/pipeline"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9020074"},{"key":"e_1_3_5_97_1","unstructured":"Lehoux D In vivo efficacy of CF-370 alone and in addition to amikacin in the rabbit acute pneumonia model caused by extensively drug-resistant (XDR) Pseudomonas aeruginosa. ECCMID 2022."},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.1.316-322.2005"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02218-12"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274815"},{"key":"e_1_3_5_101_1","unstructured":"[cited 2023 Dec 15]. Available from: www.peptilogics.com\/pipeline"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01441-21"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86155-9"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11091201"},{"key":"e_1_3_5_105_1","unstructured":"[cited 2023 Dec 16]. Available from: www.omnixmedical.com\/pipeline\/"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2018.1441024"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa529"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01541-19"},{"key":"e_1_3_5_109_1","unstructured":"[cited 2023 Dec 13]. Available from: www.spexisbio.com\/pipeline"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.718213"},{"key":"e_1_3_5_111_1","unstructured":"[cited 2024 Jan 1]. Available from: www.novabiotics.co.uk\/pipeline"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115739"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30805-3"},{"key":"e_1_3_5_114_1","unstructured":"[cited 2024 Jan 1]. Available from: www.eagleus.com\/pipeline"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa236"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11010104"},{"key":"e_1_3_5_117_1","unstructured":"[cited 2023 Dec 6]. Available from: www.clarametyx.com\/pipeline"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-022-03068-5"},{"key":"e_1_3_5_119_1","unstructured":"[cited 2023 Dec 6]. Available from: www.infextx.com\/pipeline"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2156-1"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.001170"},{"key":"e_1_3_5_122_1","unstructured":"[cited 2024 Jan 1]. Available from: www.alopexx.com\/pipeline"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00054-22"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00184-6"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01258-23"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2310307"},{"key":"e_1_3_5_127_1","article-title":"Infectious diseases society of america 2023 guidance on the treatment of extended-spectrum \u03b2-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa)","author":"Tamma PD","year":"2023","unstructured":"Tamma PD, Bonomo RA, Mathers AJ. Infectious diseases society of america 2023 guidance on the treatment of extended-spectrum \u03b2-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis. 2023.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.107081"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3627"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00614-23"},{"key":"e_1_3_5_131_1","doi-asserted-by":"crossref","first-page":"e0258720","DOI":"10.1128\/AAC.02587-20","article-title":"Development of a broth microdilution method for exebacase susceptibility testing","volume":"65","author":"Oh JT","year":"2021","unstructured":"Oh JT, Ambler JE, Cassino C, et al. Development of a broth microdilution method for exebacase susceptibility testing. Antimicrob Agents Chemother. 2021;65:e0258720.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2024.2326028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T13:37:53Z","timestamp":1727185073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2024.2326028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":129,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,2]]}},"alternative-id":["10.1080\/13543784.2024.2326028"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2024.2326028","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}